HomeHealthcare & Life SciencesPharmaceuticals Gamma Aminobutyric Acid Transaminase Deficiency Treatment Market

Middle East And Africa Gamma Aminobutyric Acid Transaminase Deficiency Treatment Market Size & Outlook, 2026-2034


Middle East And Africa Gamma Aminobutyric Acid Transaminase Deficiency Treatment Market Insights

  • According to Reed Intelligence analysis, the Middle East And Africa Gamma Aminobutyric Acid Transaminase Deficiency Treatment Market size stood at USD 17.59 Million in 2025 and is forecasted to reach USD 38.49 Million by 2034.
  • The market is projected to grow at a CAGR of 9.15% between 2026 and 2034.
  • By segment, Drug Therapy was the leading Treatment Type in terms of market size in 2025.
  • Supportive Therapy is expected to be the most lucrative Treatment Type segment, exhibiting the fastest growth throughout the forecast period.

Other Key Findings


  • Middle East And Africa represented 9.51% of the global Gamma Aminobutyric Acid Transaminase Deficiency Treatment Market size in 2025.
  • By 2034, United States is estimated to hold the largest position in the global market in terms of size.
  • Turkey is estimated to remain the fastest-growing market in Middle East and Africa, advancing to USD 1.97 Million by 2034.

Report Summary

Report Scope Details
Base Year for Study 2025
Study Period 2022-2034
Historical Period 2022-2024
Forecast Period 2026-2034
Market Size In 2025 USD 17.59 Million
Market Size In 2034 USD 38.49 Million
Largest segment Drug Therapy
Units Revenue in USD Million
CAGR 9.15% (2026-2034)
Segmnetation Covered
Middle East and Africa
  1. United Arab Emirates
  2. Saudi Arabia
  3. South Africa
  4. Egypt
  5. Nigeria
  6. Turkey
Treatment Type
  1. Drug Therapy
  2. Gene Therapy
  3. Supportive Therapy
Route of Administration
  1. Oral
  2. Injectable
Distribution Channel
  1. Hospital Pharmacies
  2. Retail Pharmacies
  3. Online Pharmacies
End-Use
  1. Hospitals
  2. Specialty Clinics
  3. Homecare Settings
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

Related Reports